1. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial 
Kate E Duhig, MRCP, Jenny Myers, PhD, Paul T Seed, CStat, Jenie Sparkes, BSc, Jessica Lowe, FRANZCOG, Rachael M Hunter, MSc, Prof Andrew H Shennan, MD, Prof Lucy C Chappell, PhD Rachna Bahl, Gabrielle Bambridge, Sonia Barnfield, Jo Ficquet, Carolyn Gill, Joanna Girling, Kate Harding, Asma Khalil, Andrew Sharp, Nigel Simpson, Derek Tuffnell Kate E Duhig, MRCP, Jenny Myers, PhD, Paul T Seed, CStat, Jenie Sparkes, BSc, Jessica Lowe, FRANZCOG, Rachael M Hunter, MSc, Prof Andrew H Shennan, MD, Prof Lucy C Chappell, PhD Rachna Bahl, Gabrielle Bambridge, Sonia Barnfield, Jo Ficquet, Carolyn Gill, Joanna Girling, Kate Harding, Asma Khalil, Andrew Sharp, Nigel Simpson, Derek Tuffnell 
The Lancet 
DOI: /S (18)
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

2. Figure 1 Trial profile The Lancet DOI: (10.1016/S0140-6736(18)33212-4)
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

3. Figure 2
Proportion of women diagnosed with pre-eclampsia when revealing versus concealing circulating placental growth factor concentrations from clinicians, over days (A) and weeks (B)
Data are mixed-effects log-normal regression curves.
The Lancet DOI: ( /S (18) )
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions